REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Cardiovascular Del Cesar S.A. (Colombia)

Main Activities: General Medical and Surgical Hospitals
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Research and Development in the Social Sciences and Humanities
Full name: Instituto Cardiovascular Del Cesar S.A. Profile Updated: August 01, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Instituto Cardiovascular Del Cesar S.A. is a company based in Colombia, with its head office in Valledupar. The company operates in the General Medical and Surgical Hospitals industry. The enterprise was incorporated on April 07, 2005. It currently has a total number of 200 (2017) employees. From the latest financial highlights, Instituto Cardiovascular Del Cesar S.A. reported a net sales revenue increase of 31.66% in 2023. Its’ total assets recorded a growth of 11.6%. The net profit margin of Instituto Cardiovascular Del Cesar S.A. increased by 2.76% in 2023.

Headquarters
Cra 16 No. 16A - 42
Valledupar; Cesar;

Contact Details: Purchase the Instituto Cardiovascular Del Cesar S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Instituto Cardiovascular Del Cesar S.A. report to view the information.
Outstanding Shares:
Purchase the Instituto Cardiovascular Del Cesar S.A. report to view the information.
Incorporation Date:
April 07, 2005
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Cardiovascular Del Cesar S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
31.66%
Total operating revenue
31.66%
Operating profit (EBIT)
202.95%
EBITDA
148.26%
Net Profit (Loss) for the Period
179.31%
Total assets
11.6%
Total equity
0.19%
Operating Profit Margin (ROS)
5.86%
Net Profit Margin
2.76%
Return on Equity (ROE)
6.53%
Debt to Equity Ratio
-5.43%
Quick Ratio
0.05%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?